Principles of Pharmacovigilance

Please report any adverse events

Main location

Address Ivana Franko, 8, Moscow, 121108
Mail address moscow@egis.ru
Phone +7 (495) 363-39-66
Telefax +7 (495) 789-66-31
E-mail moscow@egis.ru

Write to us

Please report any adverse events possibly related to the products of Egis Pharmaceuticals PLC, at any of the following contacts:

E-mail: pharmacovigilance@egis.ru (please write your contact details for fast-ating feedback) 

Telephone: +7 (495) 363-39-66 (24/7).

Corporate contacts

You can use the following online contact form to send a message to our department that is responsible for the selected topic.

For Mass Media

pr@egis.hu

Quality Assurance

claims@egis.ru

For commercial partners

anna.zhironkina@egis.ru

Production sites and offices

Egis Pharmaceuticals PLC
Address: 1106 Budapest, Keresztúri street 30-38, Hungary
Phone: +36 1 803-5555
Telefax: +36 1 803-5529
Egis Pharmaceuticals PLC, Bökényföldi road
Address: 1165 Budapest, Lehel u. 116-120., Hungary
Phone: +36 1 803-4222
Telefax: +36 1 803-4222
Egis Pharmaceuticals PLC Production Site of Körmend
Address: 9900 Körmend, Mátyás kir. u. 65., Hungary
Phone: +36 94 883-100
Telefax: +36 94 410-622

About the company

Corporate information
Russian legal entity
Abbreviated
Egis Pharmaceuticals PLC
Postal address
121108, Moscow, Ivana Franko Str, 8, Russia
Headquarters
H-1106 Budapest, Keresztúri út 30-38.

Principles of Pharmacovigilance

Please report any adverse events

Principles of Pharmacovigilance

Egis Pharmaceuticals PLC is committed to the safe use of drugs. Therefore we pay special attention to the collection and evaluation of the adverse events and quality complaints experienced in relation to the use of our products.

Our aim is to provide patients, physicians and pharmacists who use our products with information, which reflects the current views of medical science and which contains all the data and knowledge necessary for the safe use of our products in order to facilitate the patients’ recovery and to minimize the risks of side effects.

To reach this goal we need the cooperation of patients, practicing physicians and pharmacists in reporting suspected adverse drug reactions noticed in their professional practice. It is our firm belief that the safety of medicinal treatment is our common interest.

Please report any adverse events possibly related to the products of Egis Pharmaceuticals PLC, at any of the following contacts:

E-mail: pharmacovigilance@egis.ru (please write your contact details for fast-ating feedback) 

Telephone: +7 (495) 363-39-66 (24/7).

WarningYour browser is out of date. Please, use an updated version! Chrome || Firefox